§ Funding Round
Series B funding round for DTx Pharma raising $100M in February 2021
Series B funding round for DTx Pharma raising $100M in February 2021
| Investor | Firm Type | Partner |
|---|---|---|
Access Biotechnology | — | — |
Domain Associates | — | — |
| Organization | — | |
MPM Capital | — | — |
| Organization | — | |
| Organization | — | |
SR One | — | — |
| Organization | — | |
| Organization | — | |
Eli Lilly and Company | — | — |
| Organization | — | |
Friedman BioVentures | — | — |
Janus Henderson Investors | — | — |
Logos Capital | — | — |
matthew hammondLEAD | Angel | matthew hammond |
Surveyor Capital | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$114M
Top Valuation
-
DTx Pharma raised $100M in a Series B round.
The round was announced on 02/01/21.
The round was led by matthew hammond.
